tuberculosis. Both clavulanate and meropenem are FDA-approved drugs, and both clavulanate and meropenem are sufficiently free of side effects to be approved for pediatric use in children over 3 months old. We constructed a large-scale functional network model in Drosophila melanogaster built around two key transcription factors involved in the process of embryonic segmentation. Analysis of the model allowed the identification of a new role for the ubiquitin E3 ligase complex factor SPOP. In Drosophila, the gene encoding SPOP is a target of segmentation transcription factors. Drosophila SPOP mediates degradation of the Jun kinase phosphatase Puckered, thereby inducing tumor necrosis factor (TNF)/Eiger-dependent apoptosis. In humans, we found that SPOP plays a conserved role in TNF-mediated JNK signaling and was highly expressed in 99% of clear cell renal cell carcinomas (RCCs), the most prevalent form of kidney cancer. SPOP expression distinguished histological subtypes of RCC and facilitated identification of clear cell RCC as the primary tumor for metastatic lesions.
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We constructed a large-scale functional network model in Drosophila melanogaster built around two key transcription factors involved in the process of embryonic segmentation. Analysis of the model allowed the identification of a new role for the ubiquitin E3 ligase complex factor SPOP. In Drosophila, the gene encoding SPOP is a target of segmentation transcription factors. Drosophila SPOP mediates degradation of the Jun kinase phosphatase Puckered, thereby inducing tumor necrosis factor (TNF)/Eiger-dependent apoptosis. In humans, we found that SPOP plays a conserved role in TNF-mediated JNK signaling and was highly expressed in 99% of clear cell renal cell carcinomas (RCCs), the most prevalent form of kidney cancer. SPOP expression distinguished histological subtypes of RCC and facilitated identification of clear cell RCC as the primary tumor for metastatic lesions.
O ver the last three decades, extensive molecular and genetic analyses have characterized the identity of and interactions between components of the Drosophila segmentation process (1) . Maternal factors distributed in gradients along the anterior-posterior (A-P) axis activate zygotic transcription of gap genes, which encode transcription factors that activate sets of pair-rule genes including the homeobox transcription factors Even-skipped (Eve) and Fushi tarazu (Ftz). These pair-rule proteins then directly regulate segment polarity genes that determine the internal A-P orientation of each segment. Many of the human homologs of these genes and their downstream targets play critical roles in human diseases, especially cancers (2, 3) . In an effort to extract new information from the Drosophila segmentation network, as well as to mine this network for previously unknown disease-related genes, we built a large-scale predictive network model around Ftz and Eve.
We analyzed gene expression changes between individual wild-type embryos and embryos with null mutations in ftz and eve (1) collected during a developmental time course from 2 hours until 7 hours after egg laying (AEL). By focusing on the effects of Ftz and Eve 2 to 3 hours AEL (early zygotic expression), we found 1310 genes differentially expressed between the ftz mutant and wild type, and 1074 genes differentially expressed between the eve mutant and wild type (false discovery rate < 0.001; tables S1 and S2).
Using antibodies specific for Ftz or Eve, we performed chromatin immunoprecipitation (ChIP) and mapped genome-wide transcription factor binding in cellular blastoderm embryos 2 hours AEL on custom-designed high-density DNA microarrays (4). We found 1286 Ftz-and Table 1 . MIC values for b-lactams in the presence of 2.5 mg ml -1 clavulanic acid. The XDR strains were a subset of those previously reported (18 Genes both differentially expressed and targeted by ChIP-chip binding site mapping were considered as putative direct target genes. We thus identified 137 Ftz direct target genes (Fig. 1A ) and 98 Eve direct target genes ( fig. S2 ; overlap 9 genes). Figure 1A (right) shows the locations of binding sites at Ftz or Eve direct target genes. Analysis of direct target gene annotations indicates that 39 genes (21%) regulate transcription and 74 genes (40%) are involved in developmental processes (Fig. 1A, center) ; both annotation classes were significantly enriched compared to the 9.6% and 18% of Drosophila genes annotated as transcriptional or developmental regulators, respectively (P = 1.05 × 10 −6 and P = 1.81 × 10
; hypergeometric test). A complete target list can be found in tables S5 and S6.
To extend our Ftz-Eve network model beyond direct transcriptional regulation, we included automated literature-mining methods to capture published interactions of target genes (5). We then integrated yeast two-hybrid-based protein-protein interaction data (6) into our model by connecting protein interactions between existing components in the network. To limit the size of the network, we extended the proteinprotein interaction only one degree from the direct targets of Ftz or Eve. The resulting Ftz-Eve regulatory network model included 4084 genes/ proteins and 6648 interactions between them ( fig. S3 ).
To confirm parts of the network model topology, we examined several genes that are expressed in segmental patterns (7) and validated a limited set of interactions by genetic and biochemical testing of simple predictions from our network model ( fig. S4 ). Analysis of the EveFtz network identified 150 different genes as direct targets of Eve or Ftz that also have unambiguous human homologs. From this gene set, we identified a top candidate, CG9924 or roadkill (rdx), which ranks first in network betweennesscentrality and thus constitutes a major network hub (8) (see supplemental methods and table  S8 ). The rdx gene encodes a BTB domain protein that has been shown to regulate Cubitus interruptus (Ci) degradation in the Hedgehog pathway (9, 10) . This product of the rdx gene is 79% identical to the human protein SPOP, and these proteins appear to be orthologs ( fig. S5) (9, 10) ; we refer to the rdx gene product(s) as Drosophila SPOP (D-SPOP).
Our network model indicates that the D-SPOP gene is a direct target of Ftz at 2 to 3 hours AEL and that the D-SPOP protein interacts with the Jun kinase phosphatase Puckered (Puc) (Fig. 1B) . RNA in situ hybridizations for D-SPOP mRNA in ftz mutant embryos confirmed that ftz is indeed required for D-SPOP expression in parasegments that normally express Ftz (Fig. 1C) . We did not observe significant misexpression of D-SPOP mRNA in eve mutant embryos at 2 to 3 hours AEL ( fig. S6 ), suggesting that the Ftz effects on D-SPOP mRNA expression occur before the Eve effect. We found that the D-SPOP protein segmental expression pattern was completely lost in eve mutant embryos at 6 to 7 hours AEL (Fig. 1D) , similar to the expression pattern observed for the well-characterized Ftz and Eve target gene engrailed (11, 12) . Previous studies also indicate that D-SPOP is regulated by Hedgehog (Hh) later in development, indicating another layer of D-SPOP regulation by the segment polarity system 
Knockdown of D-SPOP mRNA expression by RNA interference (RNAi) and P-element insertion mutagenesis of the D-SPOP gene resulted in severe and consistent disruption of both the peripheral and the central nervous system (CNS) (fig. S7 ). Such phenotypes are recapitulated by mutating ftz or eve and are likely due to midembryonic functions of D-SPOP when Ftz and Eve become active in the CNS (13, 14) . Furthermore, it was recently demonstrated that the Drosophila Eiger/TNF (tumor necrosis factor) pathway regulates embryonic neuroblast division (15) . Thus, we hypothesized that the function of D-SPOP in nervous tissue development may result from its interaction with Puc, which mediates a feedback loop by negatively regulating basket (Drosophila JNK) in the Drosophila Eiger/TNF pathway (16) (Fig. 1B) .
In Drosophila, ectopic expression of Eiger in neuronal cells in the developing eye induces apoptosis through the JNK pathway, resulting in a reduced adult eye size (Fig. 2, A and B) (17) . Deletion of one wild-type copy of D-SPOP or RNAi knockdown of D-SPOP mRNA partially suppresses the eye phenotype of Eiger expression (Fig. 2, C and D) . Additionally, ectopic expression of D-SPOP in the developing eyes produces a small and rough eye phenotype (Fig. 2E) . A physical interaction between D-SPOP and Puc was confirmed by both in vitro pull-down and in vivo immunoprecipitation assays (Fig. 2, F and G). D-SPOP contains two conserved domains, a MATH domain and a BTB/POZ domain (18) . MEL-26, the Caenorhabditis elegans ortholog of human SPOP, was first identified as a BTB protein that serves as an adaptor of Cul3-based ubiquitin ligase (18) . Recently, human SPOP has been shown to mediate ubiquitination of death domain-associated protein (Daxx) (19) , the Polycomb group protein BMI-1, the histone variant MacroH2A (20) , and the transcription factor Gli (10). We found that Puc protein abundance was reduced when coexpressed with D-SPOP in S2 cells (Fig. 2H) . Furthermore, D-SPOP promoted Puc ubiquitination in S2 cells treated with the proteasome inhibitor MG132 (Fig. 2I) . Together, these results indicate that D-SPOP induces apoptosis in the Eiger/TNF pathway by mediating Puc ubiquitination and degradation (Fig. 2J) .
Homologs of several Ftz and Eve targets have been shown to be involved in human cancers (21) ; a large body of experimental and clinical data indicates that defects in ubiquitin signaling pathways have roles in the genesis of different tumor types (22) ; and JNK activation is required for cellular transformation induced by RAS, an oncogene mutated in 30% of human cancers (23) . To determine whether human SPOP's role in modulating TNF-stimulated JNK signaling is conserved, we treated human embryonic kidney 293 (HEK293) cells overexpressing SPOP with TNF-a, then analyzed the abudance of phosphorylated JNK (P-JNK) and phosphorylated c-Jun (P-c-Jun). Consistent with its role in Drosophila as an activator of the pathway, overexpression of SPOP increases the amount of P-JNK and P-c-Jun, indicating conservation of its function in modulating the JNK pathway (Fig. 3A) .
To test whether SPOP is associated with human cancers, we screened SPOP protein abundance with tissue microarrays that contained 20 tumors from each of 18 different organs. We found that 85% of renal cell carcinomas (RCCs) showed high expression of SPOP, whereas normal kidney tissue was uniformly negative (Fig. 3B and Table 1 ). To further investigate the potential of SPOP as a marker, we designed a large tissue array containing more than 300 RCC samples. Of the tumor samples, 77% were positive for SPOP staining; normal kidney samples were all negative (Table 2) .
RCC is a heterogeneous group of tumors with distinct histological subtypes, including clear cell, papillary, chromophobe, and other rare subtypes in addition to oncocytoma, which is a benign solid renal tumor (24) . Most RCCs (up to 75%) are of the clear cell type and can be subtyped by hematoxylin and eosin staining morphology, but diagnostic difficulties arise when clear cell RCCs display morphologic features that overlap with those of other RCC subtypes and nonrenal tumors (25) (26) (27) . At present, a panel of immunohistochemical markers is used to differentiate the major subtypes of RCC in difficult cases (26, 27) . Unfortunately, these panels lack a specific and sensitive marker that is positive in clear cell RCC (26, 27) . Recently, carbonic anhydrase IX has been proposed as a positive marker for clear cell RCC, but it is positive in other RCCs and several other tumor types as well (28) (29) (30) . Patient tumor samples in our studies were classified into different types according to the recent World Health Organization classification system. We found that 99% of the clear cell RCCs and 86% of the chromophobe RCCs showed positive staining for SPOP, but only 22% of papillary-type RCCs were SPOP positive. Four out of 31 papillary RCCs from the general pathology reports were shown to be misdiagnosed as clear cell RCCs when the tumor biopsies were reanalyzed by urological pathologists. All four of these misdiagnosed RCCs have papillary architecture and were subsequently shown to stain positive for SPOP. Our tissue array also included benign oncocytomas, which can mimic RCC both clinically and pathologically, in turn potentially subjecting patients to unnecessary surgeries and additional morbidities. Only 6% of oncocytomas showed weak positive staining. These results indicate that SPOP is a highly sensitive and specific diagnostic biomarker for clear cell RCC and can help distinguish histological subtypes of RCC.
Up to 30% of RCC patients present with metastases; half of the rest will develop metastases later in their course, 90% of which are clear cell RCCs. Accordingly, we further screened for SPOP staining in confirmed metastases from RCC and found that 97% of them were positive ( Table 3 ), indicating that SPOP may be a useful biomarker to identify clear cell RCC as the site of the primary tumors in cases of metastases of unknown origin. Together, our results demonstrate that novel functions for conserved molecules can readily be extracted from data mining of large-scale networks in Drosophila and provide a strategy for rapid identification of factors that may have clinical relevance as biomarkers or drug targets for human diseases. 
